AEYE vs. DH, DOMO, RZLV, HUYA, CANG, DADA, PERI, LGTY, BAND, and CRNC
Should you be buying Audioeye stock or one of its competitors? The main competitors of Audioeye include Definitive Healthcare (DH), Domo (DOMO), Rezolve AI (RZLV), HUYA (HUYA), Cango (CANG), Dada Nexus (DADA), Perion Network (PERI), Logility Supply Chain Solutions (LGTY), Bandwidth (BAND), and Cerence (CRNC). These companies are all part of the "computer software" industry.
Audioeye vs. Its Competitors
Audioeye (NASDAQ:AEYE) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.
Audioeye has higher earnings, but lower revenue than Definitive Healthcare. Audioeye is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Audioeye had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 3 mentions for Audioeye and 2 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.27 beat Audioeye's score of 0.57 indicating that Definitive Healthcare is being referred to more favorably in the news media.
51.1% of Audioeye shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 28.8% of Audioeye shares are held by company insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Audioeye presently has a consensus price target of $26.40, suggesting a potential upside of 125.26%. Definitive Healthcare has a consensus price target of $5.10, suggesting a potential upside of 30.10%. Given Audioeye's stronger consensus rating and higher possible upside, research analysts plainly believe Audioeye is more favorable than Definitive Healthcare.
Audioeye has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.
Audioeye has a net margin of -13.28% compared to Definitive Healthcare's net margin of -206.05%. Audioeye's return on equity of 36.54% beat Definitive Healthcare's return on equity.
Summary
Audioeye beats Definitive Healthcare on 11 of the 16 factors compared between the two stocks.
Get Audioeye News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEYE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AEYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Audioeye Competitors List
Related Companies and Tools
This page (NASDAQ:AEYE) was last updated on 7/12/2025 by MarketBeat.com Staff
